Q4 2016 Holdings
Filed 2017-02-14 | 9 holdings | $62.3M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Aclaris Therapeutics, Inc.(ACRS) | Common Stock | 00461U105 | $62.1M | 2,289,480 | 99.8% |
| Spark Therapeutics, Inc. | Common Stock | 84652J103 | $45.2K | 904,986 | 0.1% |
| Versartis, Inc. | Common Stock | 92529L102 | $35.2K | 2,361,978 | 0.1% |
| Natera, Inc.(NTRA) | Common Stock | 632307104 | $18.2K | 1,550,280 | 0.0% |
| Auris Medical Holding AG | Common Shares | H03579101 | $6.2K | 5,818,175 | 0.0% |
| Mirna Therapeutics, Inc. | Common Stock | 60470J103 | $5.4K | 2,974,812 | 0.0% |
| Histogenics Corporation | Common Stock | 43358V109 | $3.5K | 2,077,040 | 0.0% |
| Innocoll Holdings PLC | Ordinary Shares | G4783X105 | $1.5K | 2,103,173 | 0.0% |
| Sophiris Bio Inc. | Common Stock | 83578Q209 | $560 | 200,000 | 0.0% |